Verificando…
Traduzido automaticamente. Doses e advertências: confira o original em inglês. Ler em inglês
Início / Registado na Nigéria / Brimosopt 0.2% Eye Drop

Brimosopt 0.2% Eye Drop

NAFDAC Reg. No. A4-101222 · Drug

Registered with NAFDAC. Registration activeAs of 6 November 2026 · synced automatically from official sources.
Product
Brimosopt 0.2% Eye Drop
Número NAFDAC
A4-101222
Princípio ativo
Brimonidine Tartrate
Dosagem
0.2%
Forma
Eye drops
Tamanho da embalagem
1 x 10 mL (in sterile plastic vial)
Manufacturer
Not listed
Applicant (holder)
NCI PharmChem Industries Limited
Approved
27 Mar 2025
Situação
Active View on NAFDAC ↗
Registro válido até
26 Mar 2030
Alertas da OMS
None found
Community reports
None
Times checked
0

About the medicine: Brimonidine tartrate: uses, dosage and brands worldwide

What we found

  • Brimosopt 0.2% Eye Drop is on the NAFDAC register with an active registration (A4-101222). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Brimosopt 0.2% Eye Drop

O que diz a bula oficial. Se um médico receitou, siga a receita. Se a bula da sua caixa for diferente, vale a da sua caixa.

Para quem é

Relieves redness of the eye due to minor eye irritations

Como tomar e com que frequência
  • Adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours
  • Do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch tip of container to any surface replace cap after each use
  • Children under 5 years of age: consult a doctor
Talk to a doctor first if

you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days

Warnings

For external use only Do not use if solution changes color or becomes cloudy Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Pregnancy and breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

How to store it

Keep out of reach of children.

Se esquecer uma dose

Tome assim que lembrar, a menos que esteja quase na hora da próxima dose. Nesse caso, pule a dose esquecida. Nunca tome duas doses de uma vez para compensar. Confira a bula, pois alguns medicamentos são diferentes.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-03-31.

Label for brimonidine tartrate, the active ingredient registered with NAFDAC.

Check your pack of Brimosopt 0.2% Eye Drop

Add the expiry date on your pack for a full Trust Score.

Ou tire fotos da caixa
Restam 3 verificações grátis hoje Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Brimosopt 0.2% Eye Drop

What is in Brimosopt 0.2% Eye Drop?

Brimosopt 0.2% Eye Drop contains Brimonidine Tartrate (0.2%), as eye drops, according to its NAFDAC registration record.

Is Brimosopt 0.2% Eye Drop registered with NAFDAC?

Yes. Brimosopt 0.2% Eye Drop is listed on the NAFDAC register under registration number A4-101222, and its registration is active as of 6 November 2026.

Has Brimosopt 0.2% Eye Drop been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Brimosopt 0.2% Eye Drop in our automatically synced alert list.

How can I check that my pack of Brimosopt 0.2% Eye Drop is genuine?

Run a free authenticity scan with the NAFDAC number A4-101222, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Brimosopt 0.2% Eye Drop?

Follow your prescription or the leaflet in your pack. The official label says: adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch …

What is Brimosopt 0.2% Eye Drop used for?

relieves redness of the eye due to minor eye irritations (Summarised from the official U.S. FDA label for brimonidine tartrate. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Brimosopt 0.2% Eye Drop? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.